Thursday May 25th 2017

Archive for September, 2015

Methylprednisolone induced liver injury: Case report and literature review

Methylprednisolone induced liver injury: Case report and literature review

This article is protected by copyright. All rights reserved. (Source: Journal of Digestive Diseases) [Read More]

Effects of whole body vibration on hormonal & functional indices in patients with multiple sclerosis.

Effects of whole body vibration on hormonal & functional indices in patients with multiple sclerosis.

CONCLUSIONS: The results suggest that low intensity exercise and WBV training have some beneficial impact on functional and physical indices of MS patients. PMID: 26609037 (Source: Indian J Med Res) [Read More]

Tribbles and arthritis: what are the links?

Tribbles and arthritis: what are the links?

Authors: Rowan AD, Litherland GJ Abstract The pseudo-kinase family of tribbles (TRIB) proteins has been linked to a variety of cell signalling pathways and appears to have functionally divergent roles with respect to intracellular protein degradation and the ability to [Read More]

 Page 1 of 103  1  2  3  4  5 » ...  Last » 

Latest Topics

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]

Experimental treatment tempers HLH, MS symptoms in mouse models, study shows

Experimental treatment tempers HLH, MS symptoms in mouse models, study shows

Immune diseases like multiple sclerosis and hemophagocytic lymphohistiocytosis unleash destructive waves of [Read More]

Celgene ’s Phase III trial of ozanimod for RMS meets primary endpoint

Celgene ’s Phase III trial of ozanimod for RMS meets primary endpoint

US-based biopharmaceutical firm Celgene has reported positive results from the Phase III RADIANCE clinical trial of [Read More]